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Antinatriferic activity in human plasma following acute and
chronic salt-loading. Increasing evidence suggests that a humoral
natriuretic factor, in addition to intrarenal physical factors and
aldosterone, affects renal sodium reabsorption. We previously iso-
lated a natriuretic plasma fraction IV, which was also anti-
natriferic, in the isolated frog skin. In the present study, renal
function and antinatriferic plasma activity were investigated in 17
human subjects undergoing acute or chronic extracellular fluid
expansion. In six of 12 subjects, no natriuretic response to rapid
iv. infusion of isotonic saline was observed (urinary excretion of
sodium [UNV1, 0.23 0.06 vs. 0.12 0.07 mEq/min), while the
remaining subjects responded with an increase in UNV from 0.16
+ 0.05 to 0.65 0.07 mEq/min. Plasma antinatriferic activity
was demonstrable during rapid saline infusion in "responders"
(potential difference [PD], —21.8 + 1.7%; short-circuit current
(SCC), —18.3 1.6%) but was absent in "non-responders"(PD, +9.2 6.2%; SCC, +4.2 8.0%). In analogy to the so-
called "escape phenomenon" in patients with primary aldosteron-
ism, preexpansion antinatriferic plasma activity significantly in-
creased following high sodium intake (PD, from —23.2 + 4.4 to
—40.2 + 6.5%; SCC, from —24.2 3.8 to —42.0 6.4%). The
dose-related antinatriferic effect of fraction IV was not reversed by
vasopressin. The results suggest that, probably depending on the
previous state of body sodium balance, a circulating antinatriferic
factor of low molecular weight, which may also be natriuretic, may
be released to modulate renal sodium reabsorption in response to
changes in extracellular fluid volume.
Activité anti-natriférique dans le plasma humain après une charge
en sel aiguë ou chronique. Un nombre croissant d'arguments sug-
gère qu'un facteur natriurétique humoral affecte La réabsorp-
tion rénale de sodium a côté des facteurs physico-chimiques et de
I'aldostérone. Ainsi nous avons préalablement isolé une fraction
natriurétique plasmatique IV qui est aussi anti-natriférique sur Ia
peau de grenouille isolée. Dans cc travail Ia fonction rénale et
l'activité plasmatique anti-natriférique ont été étudiées chez 17
sujets au cours d'une expansion aigu ou chronique des liquides
extracellulaires. Chez 6 des 12 sujets aucune réponse natriurétique
a une perfusion rapide de solute sale isotonique n'a etC trouvCe
(UNV: 0,23 0,06 vs. 0,12 0,07 mEq/min). Les autres sujets,
cependant, ont repondu par une augmentation de UNV de 0,16 +
0,05 a 0,65 0,07 mEq/min. L'activitC anti-natrifCrique plasma-
tique a été misc en evidence au cours de l'administration rapide
de solute sale isotonique seulement chez ceux qui ont eu une
augmentation de Ia natriurése (PD: —21,8 1,7%; SCC:
—18,3 + 1,6%), mais était absente chez les autres (PD: +9,2
+ 6,2%, SCC: 4,2 + 8,0%). Dc facon analogue au phC-
nomCne d'échappement observe chez les malades atteints
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d'hyperaldostCronisme primaire, I'activitC anti-natrifCrique du
plasma a augmenté significativement après I'ingestion d'une ali-
mentation riche en sodium (PD: —23,2 + 4,4% et —40,2 6,5%;
SCC: —24,2 3,8% et —42,0 6,4%). L'effet anti-natrifCrique,
dépendant de Ia dose, de Ia fraction IV, n'a pas été aboli par Ia
vasopressine. Les résultats suggCrent qu'en fonction, probable-
ment, de I'état antérieur du bilan du sodium, un facteur anti-
natrifCrique circulant de faible poids molCculaire, qui peut aussi
Ctre natriurétique, peut être libéré pour moduler Ia reabsorption
rénale de sodium en rCponse aux modifications du volume des
liquides extra-cellulaires.
It is generally accepted that the renal regulation of
body sodium and water homeostasis is mediated by
intrarenal physical and hormonal factors, as well as
by extrarenal hormones such as aldosterone and anti-
diuretic hormone. Although several investigators
[1—9] have presented accumulating evidence suggest-
ing the existence of a circulating natriuretic hormone
which modulates renal tubular sodium reabsorption
in response to changes in extracellular fluid volume
(ECV), its existence has not yet been definitely con-
firmed. In search of such humoral natriuretic activity
and its possible mode of action, we have previously
shown that acute expansion of the ECY in the rat is
accompanied by a slight decrease in sodium-potas-
sium-activated adenosine triphosphatase (Na-K-ATP-
ase) activity with an increase in ATP-concentration
in renal cortical tissue and an increase in medullary
enzyme activity [10]. In addition, one fraction of
plasma from expanded rats and dogs, isolated by
column chromatography, was found to inhibit renal
Na-K-ATPase activity in vitro [11] and to be anti-
natriferic in the isolated frog skin [5]. This fraction
IV was also shown to be natriuretic when injected in
the bioassay rat [5].
To further explore the possible role of this humoral
activity, in the present study the antinatriferic effects
of plasma from human subjects undergoing acute or
chronic ECV-expansion were investigated. Fractions
IV were therefore isolated from plasma of subjects
rapidly infused with isotonic saline and—in analogy
to chronic mineralocorticoid administration and high
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Blood pressure
Patient
no. Sex
Age
yr
mm Hg
Supine Upright
I m 39
Group IA
145/90 140/95
2 f 23 120/80 120/85
3 m 22 135/90 130/90
4 f 35 140/85 135/90
5 f 27 125/85 130/85
6 m 22 135/90 135/90
7 f 24
Group lB
110/60 100/70
8 f 34 105/70 100/75
9 f 18 90/60 80/65
10 f 36 120/80 105/70
II f 21 95/75 90/70
12 f 50 100/70 90/60
salt intake, maneuvers known to induce the so-called
"escape phenomenon" [121—from plasma of patients
with primary aldosteronism during low and high salt
diets. To further characterize this plasma fraction, its
stability, dose-effect relationship, and possible inter-
ference with epithelial cell membrane permeability
were investigated.
Methods
Group I. Acute expansion of the ECV with isotonic
saline (group I) was induced in 12 subjects aged 18 to
50 yr (Table 1). Group IA consisted of six medical
students in whom random checks of daily urinary
volume and sodium revealed an average sodium ex-
cretion of 232 21 mEq/24 hr. They were hospi-
talized only on the day of this study. Group lB was
comprised of six otherwise normal females who were
hospitalized because of previous syncopes due to
chronic arterial hypotension or postural hypotension
without evidence of cardiac, renal, hepatic, neuro-
logic, or endocrine (e.g., adrenocortical insufficiency,
VE
Fig. 1. Gel-filtration patterns of human plasma elutedfrom Sephadex
G-25 fine column (2.5 X 35 cm; V = elution volume). For details
see Methods.
hypothyroidism, Bartter's syndrome) disorders. They
were on a regular hospital diet with a daily intake of
120 to 140 mEq of sodium and 60 mEq of potassium.
After overnight fasting, all subjects received 1,500
ml of water between 7:00 and 9:00 A.M., and an i.v.
infusion of isotonic saline was started at 9:00 A.M.
with an infusion rate of 30 mI/mm which was re-
duced to 16 mI/mm after 30 mm. At this rate, the
infusion was continued for 120 mm. Urine was col-
lected by voluntary voiding. Two 30-mm control
urine collection periods (8:00 to 9:00 A.M.) prior to
saline infusion were followed by five 30-mm collec-
tion periods. Blood samples were drawn from the
brachial vein into heparinized syringes before the
infusion of saline was started (preexpansion plasma)
and during the fifth urine collection period (post-
expansion plasma).
Group II. Antinatriferic plasma activity before and
during chronic salt-loading (group II) was studied in
five patients, aged 31 to 49 years, with primary al-
Table 2. Diagnostic criteria of five patients with primary aldosteronism (group 11)
Aldosterone
Plasma renin activity concentration
Patient
no. Sex
Age
yr
Blood
pressure
mm Hg
PlasmaK
mEq/liter
ng/ml/3 hr pg/mi
DiagnosisSupine Upright Supine Upright
13 f 33 230/135 3.5 0.16 0.25 400 384 Adenoma, left adrenal
(by angiography; no surgery)
14 f 39 2 10/125 2.7 0.56 0.92 920 840 Adenoma, left adrenal (surgery)
IS f 39 200/130 2.5 0.47 0.25 180 284 Adenoma, left adrenal (surgery)
16 f 31 170/110 3.5 0.16 0.16 236 376 Adenoma,rightadrenal(surgery)
17 m 49 220/130 2.7 0.16 0.16 154 102 Bilateral nodular hyperplasia (surgery)
Table I. Arterial blood pressure of six healthy subjects (group IA)
and six patients with chronic arterial hypotension or postural
hypotension (group IB).
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Fig. 2. Mean changes in potential difference (PD) and short-circuit
current (SCC) induced by pre-(O-- — — 0) and post- (•——•) ex-
pansion plasma fractions I Vfrom six healthy subjects ("responders,"
see text).
dosteronism. The diagnoses were established by bio-
chemical and angiographic means and histologically
confirmed in four of five patients (Table 2). They
were first given a low sodium diet of 60 mEq/day and
were subsequently placed on a high sodium intake of
350 mEq/day. On day five of low sodium intake (pre-
expansion plasma) and on the fifth day of high so-
dium intake (postexpansion plasma), venous blood
was collected from the brachial vein in all fasting
subjects at 8:00 a.m. Twenty-four hour urine was
collected daily and was assayed for sodium, potas-
sium, and aldosterone excretion.
Processing of plasma samples. All blood samples
were immediately placed in ice and then centrifuged
at 4°C for 10 mm. Plasma was frozen and stored at
—18°C. Plasma samples (10 ml each) were fraction-
ated by column chromatography using Sephadex® G-
25 fine. The column was equipped with a cooling
jacket, and temperature was maintained below 6°C.
The size of the Sephadex bed was 2.5 X 35 cm with a
void volume of 75 ml as estimated from the elution of
Dextran Blue® gel. Tris-hydrochloric acid buffer
(0.01 M; pH, 6.8) was used as eluent, and descending
flow rate averaged 1 .6 ml/min. This buffer was used
since it was previously found to be suitable for the in
vitro assay of ATPase activity in the presence of
plasma fractions [11]. Single fractions of 2.0 ml were
collected in plastic tubes by an automatic fraction
collector and assayed for UV280-absorbance. On sepa-
rate occasions, concentrations of calcium in each
single fraction were determined by flame photometry,
and ninhydrin reaction was performed on aliquots of
each fraction transferred on Whatman chromatogra-
phic paper, using ninhydrin spray (Merck, Darms-
tadt). Twenty fractions which followed the elution of
salts were pooled to fraction IV (Fig. 1) and were
subsequently lyophilized at temperatures not ex-
ceeding 4°C. The resulting powder of fraction IV,
from 10 ml of plasma with an average weight of 50
mg, was stored at —18°C.
Measurement of potential d(fference (PD) and short-
circuit current (SCC) in the isolated frog skin. For
measurements of PD and SCC, the abdominal skin
of R. temporaria, transferred into tap water at room
temperature four hours prior to the time of study,
was mounted into a lucite double chamber with each
two half-chambers modified according to Ussing and
Zerahn [13]. Exposed skin surface area was 5.76 cm2,
and the volume of each half-chamber amounted to 15
ml.
Circulating Ringer's solution (215 mOsm/liter;
pH, 8.2) of the following composition was used: so-
dium chloride, 102.5 mM; sodium bicarbonate, 2.5
mM; potassium chloride, 2.5 mM; calcium chloride,
2.0 m. During an average equilibration period of
one hour, PD and SCC were measured with an auto-
matic voltage clamp device until constant baseline
values in both half-chambers were obtained for at
least 30 mm, which are indicated in the tables for
each experiment. Lyophilized plasma fraction IV in
an amount equivalent to 5 ml of original plasma was
then added to the Ringer's solution bathing the inside
surface of the skin. In six experiments, a correspond-
ing volume of buffer solution eluted from the column
in the absence of plasma resulted after lyophilization
in mean changes in PD of —0.6 2.6%, and in SCC
of —2.6 4.2%. PD and SCC were subsequently
monitored every 10 mm during one hour. Test solu-
tions were then replaced by fresh Ringer's solution
with simultaneous exchange of Ringer's solution in
the outside chamber. Concentrations of sodium, po-
tassium, and calcium—the latter because of its
known effect on epithelial cell permeability—as well
as the osmolality and pH of Ringer's solution were
measured in each experiment and were not signifi-
cantly altered in the presence of fraction IV (sodium,
Fraction IV
100 - 0--
Ringer
scc
PD
—
Co
Co
C00
C))
Co0CC
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C)
a
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Antinatriferic plasma factor after salt-loading 217
Table 3. Endogenous creatinine clearance (Ccr), urinary flow rate (V), sodium (UNaV) and potassium excretion (UKV) and urinary
osmolality (Uoam) in group I subjects before and during i.v. infusion of isotonic 0.9% salinea.
Time Ccr
mm ml/min/1.73 m2
V UNaV
mi/mm mEq/mmn
UKV
mEq/mmn
Uoam
mOsm/liter
Responders
Control periodb 115 4 4.8 1.6 0.16 0.05 0.04 0.01 253 52
Saline infused at rate of 30 mI/mm
Oto 30 112 4 5.1 2.0 0.23 0.05 0.04 0.01 220 48
Saline continued at rate of 16 mI/mm
31 to6O 117 6 6.8 1.5 0.32 + 0.06 0.06 0.02 211 49
61 to9O 114±5 9.6± 1.9 0.51 +0.07 0.06±0.03 166±36
91 to 120 118 6 14.2 2.0 0.71 0.09 0.07 + 0.03 173 40
121 to 150 117 5 12.5 1.3 0.65 0.07 0.06 0.02 142 37
Control period' 113 8
Nonresponders
0.61 0.15 0.12 0.07 0.03 0.01 960 132
Saline infused at rate of 30 mI/mm
0 to 30 98 12 0.82 0.25 0.17 0.04 0.05 0.02 850 + 112
Saline continued at rate of 16 mI/mm
31 to 60 86 2c 0.78 0.26 0.18 0.04 0.04 0.Ol 906 Ill
61 to9O 99 7 1.06 0.42 0.20 0.05 0.04 0.0! 807 121
91 to 120 101 11 1.05 0.39 0.19 0.05 0.03 + 0.02 764 36
121 to 150 99 10 1.02 + 0.32 0.23 0.06 0.03 0.01 817 103
a Presented are mean values of six
"responders" and six "nonresponders.b Mean of two 30-minute control periods of each individual was used for calculation (see Methods).
Vs. control: P < 0.01.
Table 4. Effects of plasma fractions IV from acutely ECV-expanded subjects (group 1) on the potential difference (PD) and short-circuit
current (SCC) of the isolated frog skin 60 mm after addition to the inside bathing Ringer's solutiona
Patient
Baseline 60 mm after addition of fraction IV
PD SCC
PD, % change SCC, % change
Before During Before During
no. mV uA/cm2 saline saline
1 75/64b 72/70b
Responders
—4 —29 +7 —20
2 52/58 56/58 +13 —19 0 —12
3 64/64 68/70 —6 —17 +15 —23
4 81/70 86/80 0 —22 —2 —18
5 47/4! 60/58 +31 —20 —7 —16
6 52/47 94/98 0 —24 +3 —21
Mean +5.7 —21.8 +2.7 —18.3
SEM 5.7 1.7 3.1 1.6
P =o.ooi
Nonresponder
P<0.OOl
7 48/57k' lO2/lO2b —9 —6 +12 +22
8 40/52 84/90 —l +20 0 +2
9 82/87 80/100 +8 +21 —17 —15
10 46/57 56/56 +17 +25 —2 —2
II 59/63 56/58 —II —Il —12 —IS
12 75/70 68/70 —5 +6 +33 +33
Mean —0.2 +9.2 +2.3 +4.2
SEM 4.4 6.2 7.4 8.0
P NS NS
a Values represent percent of changes in PD and SCC induced by pre- and postexpansion fractions IV.
b Values of both halves of the skin.
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Aldo-
Patient
no.
sterone Plasma
excretion V UNV UKV K
/.Lg/24 hr rn1/24 hr mEq/ 24 hr mEq/liter
13
Low sodium intake (60 mEq/day)
7 1300 70 41 4.4
14 37 1200 65 45 4.0
IS 26 900 61 43 2.7
16 56 1030 67 59 3.6
17 25 1320 63 43 3.0
High sodium intake (350 rnEq/day)
13 18 3200 250 100 3.9
14 61 2600 240 130 3.0
15 38 3080 373 III 2.5
16 36 2040 280 95 3.0
17 13 1870 322 65 2.4
106 + 2 mEq/liter; potassium, 2.7 0.1 mEq/liter;
calcium, 2.2 0.1 mEq/liter; osmolality, 219 6
mOsm/liter; pH, 8.1 0.1). Pre- and postexpansion
plasma fractions were assayed in parallel on both
halves of the same skin. The origin of coded fractions
was unknown to the technician performing the ex-
periments. Data are expressed as percent of change
from control baseline values.
To study the stability of antinatriferic activity dur-
ing storage, aliquots of lyophilized pooled post-
expansion plasma fraction IV from "responders"
were repeatedly assayed after six weeks and six
months of storage at —18°C. A dose-effect relation-
ship of the antinatriferic activity was assessed by
adding pooled lyophilized plasma fraction IV to the
I I
—20 0 2040 6080100120 —20 0 2040 6080100120
Time, rn/n
Fig. 3. A. Effects of pooled fractions I Vfrom EC V-expanded healthy
subjects on potential difference (PD) and short-circuit current (5CC)
when added in amounts equivalent to 2.5 (A). 5 (0), and/U () rn/of
plasma. B. Mean changes in PD and SCC induced by vasopressin
after exposure of the skin to antinatriferic plasma fraction IV (•—
—•) as compared to the effects of vasopressin in untreated skins(0 — — 0). Values represent mean SEM of three experiments.
inside bathing Ringer's solution in amounts equiva-
lent to 2.5, 5, and 10 ml of original plasma.
To investigate the effects of vasopressin on fraction
IV-inhibited PD and SCC, in three experiments ly-
sine-vasopressin in an amount to achieve a concen-
tration of 100 mU of vasopressin per ml of Ringer's
solution was added to the inside bathing solution 60
mm after application of 25 mg of fraction IV equiva-
lent to 5 ml of original plasma. Baseline membrane
electrical resistance of the three skins was 1,235,
1,250, and 1,570 Ohm X cm2, respectively, Plasma
renin activity [14] (normal value: supine, 0.3 to 3
Table 6. Percent changes in potential difference (PD) and short-circuit current (SCC) of the isolated frog skin at 20 and 60 mm after addition
of plasma fractions IV from patients with primary aldosteronism on low and high salt intake to the inside bathing Ringer's solutiona
Baseline
After addition of fraction IV
40 mm after replacement
with fresh Ringer's solution20 mm 60 mm
PD
% change
SCC
% change
PD
%change
SCC
% change
PD SCC
% change % change
Patient
no.
PD SCC
rnV /crn2
Low High
Na Na
Low High
Na Na
Low High
Na Na
Low High
Na Na
Low High Low High
Na Na Na Na
13
14
15
16
17
61/63b 92/94b
80/86 88/100
55/52 76/72
50/57 46/48
53/61 74/84
—14 —18
—17 —27
—15 —23
—18 —50
+3 —30
—10 —24
—27 —28
—18 —20
—7 —33
—8 —24
—24 —26
—27 —39
—35 —30
—22 —62
—8 —49
—22 —33
—35 —67
—30 —34
—21 —40
—8 —36
+1 —8 —5 0
—18 0 —34 —33
—8 —9 +2 +8
—3 +1 +16 —3
—7 —II +1 —12
Mean
SEM
P
—12.2 —29.6
3.9 5.5
P < 0.05
—14.0 —25.8
3.8 2.2
P < 0.05
—23.2 —41.2
4.4 6.5
P = 0.05
—24.2 —42.0
3.8 6.4
P < 0.05
—7.0 —5.4 —4.0 —8.0
3.2 2.5 8.3 7.0
Recovery of PD and SCC 40 mm after replacement of fraction IV containing solution by fresh Ringer is shown in last column.
Values are of both halves of the skin.
Table 5. Urinary volume (V) and excretion of aldosterone,
sodium(UNV), and potassium (UKV) and plasma potassium
concentration of patients with primary aldosteronism during low
(60 mEq/day) and high (350 mEq/day) dietary sodium intake
A B
150
at
I:
g 100
C
50
Fraction tV Ringer
$
100 mU/mt
vasopressin
Fraction IV Ringer
+ +
'.4---'
'I
,, scc
'PD
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ng/ml/3 hr), plasma aldosterone concentration [15]
(normal value: supine, 20 to 120 pg/mI), and urinary
aldosterone- I 8-glucuronide excretion [16] (normal
value: 2 to 14 g/24 hr) were determined by radio-
immunoassay methods. Concentrations of creatinine
in plasma and urine were measured by conventional
autoanalyzer methods. Concentrations of sodium,
potassium, and calcium were determined by flame
photometry. The pH determination was performed
with a pH micro-electrode (Beckmann). Osmolality
was measured with an osmometer (Advanced). Gb-
merular filtration rate was calculated as endogenous
creatinine clearance by using the conventional clear-
ance formula. For statistical analysis of results a
double-tail Student's t test was used. Data are pre-
sented as mean + SEM.
Results
Urinary electrolyte excretion and plasma anti-
natriferic activity during acute expansion of the ECV.
During the two control periods before i.v. adminis-
tration of isotonic saline in six healthy subjects
(Group IA), mean urinary osmolality was 253
mOsm/liter, and urine flow rate was 4.8 mI/mm with
a mean sodium excretion of 0.16 mEq/min. They
responded to the infusion of isotonic saline with
marked increases in urinary flow rate and sodium
excretion and a progressive fall in urine osmolality.
No change in endogenous creatinine clearance oc-
curred (Table 3).
In contrast, the six subjects of group lB who had
chronic arterial hypotension or postural hypotension
revealed significantly higher urine osmolalities and
lower urinary flow rates, despite an identical water-
load during the control periods. Subsequently,
urinary flow rates, sodium and potassium excretion,
and urinary osmolalities only slightly changed during
the 150 mm-period of rapid infusion of 2.820 ml of
saline. This was accompanied by a fall in creatinine
clearance which was significantly lowered between 30
and 60 mm of saline infusion (P < 0.01) (Table 3).
When plasma fractions IV, obtained before and
during saline infusion, were assayed for their anti-
natriferic activity in the isolated frog skin, the effects
on PD and SCC correlated well with the difference in
renal response to saline administration noted be-
tween both groups of subjects. Preexpansion plasma
fractions IV did not affect SCC and insignificantly
increased PD (P > 0.25) (Fig. 2). When post-
expansion fractions IV from subjects with natriuretic
response to acute expansion of their ECV were added
to the inside bathing Ringer's solution, an immediate
fall in PD and SCC was observed (Fig. 2), reaching
its maximum after 60 mm (Table 4). This effect was
almost completely reversed when fraction IV con-
taining solution was replaced by fresh Ringer's solu-
tion (Fig. 2). In contrast, when the effects on PD and
SCC of pre- and postexpansion plasma fractions IV
of nonresponders were compared, postexpansion
fraction IV induced a slight increase in mean PD,
while SCC remained unchanged (Table 4).
Urinary electrolyte excretion and plasma an ti
nairiferic activity in patients with primary aldosteron-
ism during periods of low and high salt intake. In
patients with primary aldosteronism, urinary sodium
excretion ranged between 61 and 70 mEq/24 hr dur-
ing low salt intake. During high sodium intake,
urinary sodium excretion ranged between 240 and
373 mEq/24 hr with a significant increase in urinary
volume and potassium excretion and a decrease in
plasma potassium concentration. Urinary aldoste-
rone excretion remained unaltered (Table 5).
Antinatriferic activity already present in plasma
during low sodium diet significantly increased after
five days of high sodium intake.
Table 6 summarizes the changes in PD and SCC of
the isolated skin, induced by pre- and postexpansion
plasma fractions IV. Except for patient no. 15, a
systematically stronger depression of PD and SCC
was observed at 20 and 60 mm after addition of
postexpansion plasma fractions IV. This inhibitory
effect was reversible by replacing the solution con-
taining fraction IV with fresh Ringer's solution
(Table 6).
Further characterization of antinatriferic plasma
fraction IV. When aliquots of pooled postexpansion
plasma fraction IV were repeatedly assayed for their
antinatriferic activity after six weeks and six months
of storage at —18°C, a time-dependent decrease of its
effect on SCC by 19 and 34%, respectively, was noted,
and a more pronounced loss of inhibition of PD by
41% at six weeks and 69% at six months resulted.
As shown in Fig. 3A this antinatriferic effect of
plasma fraction IV appears to be dose-dependent at
the concentrations studied, i.e., in amounts equiva-
lent to 2.5, 5, and 10 ml of original plasma activity, if
we assume that no loss of activity during the separa-
tion procedure had occurred.
Furthermore, the normally observed enhancement
of sodium transport by vasopressin was blunted in
the presence of antinatriferic fraction IV (Fig. 3B).
This effect was unrelated to the baseline membrane
electrical resistance of the employed skins.
Discussion
Based on cross-circulation studies, the existence of
a humoral natriuretic factor modulating renal tubu-
lar sodium reabsorption gained indirect experimental
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support first by the studies of de Wardener et al [3]
and subsequently by those of Lichardus and Pearce
[17], Sonnenberg, Veress, and Pearce [18], and oth-
ers. Although within recent years several groups of
investigators presented more direct evidence in favor
of a natriuretic hormone capable of inhibiting tubu-
lar sodium reabsorption in the rat [I, 5—8], para-
aminohippurate (PAH) uptake [1] in rabbit kidney
slices, and sodium transport in isolated biological
membranes [2, 5, 19—21], its existence has still not yet
been definitely confirmed.
In the present study, acute expansion of the extra-
cellular volume (ECV) was induced by rapid i.v. in-
fusion of isotonic saline. Despite an identical experi-
mental protocol, no significant effects on urinary
volume, sodium excretion, or urinary osmolality oc-
curred in six subjects with arterial hypotension or
inadequate orthostatic blood pressure adjustment,
while the remaining healthy subjects responded to the
infusion of saline with a marked increase in urine
flow rate and sodium excretion and a progressive fall
in urine osmolality. While in the present study GFR
in nonresponders decreased and only slightly in-
creased in the group of responders during the in-
fusion of saline, Alexander et al [22] observed, under
similar experimental conditions, a rise in GFR in
their group of subjects who excreted more than 1,000
tEq of sodium per mm ("excreters") and an unal-
tered GFR in subjects with sodium excretion of less
than 550 iEq per mm. The authors concluded that
the natriuretic response was due to the larger de-
crease in proximal and distal fractional sodium reab-
sorption in subjects with increased GFR.
In the present study, this similar difference in so-
dium excretion between both groups of subjects was
accompanied by corresponding changes in plasma
antinatriferic activity, which was absent in non-
responding subjects.
Under experimental conditions of acute expansion
of the ECV with isotonic saline, Schrier and Earley
[23] have shown that the accompanying decrease in
hematocrjt is associated with decreased renal vascu-
lar resistance, resulting in changes in filtration frac-
tion and possibly in peritubular hydrostatic and on-
cotic pressure. Brenner and Troy [24] suggested that
glomerular-tubular balance under these conditions is
essentially maintained through changes in post-
glomerular capillary oncotic pressure. Peritubular
oncotic pressure, however, may not be the only de-
terminant of tubular sodium reabsorption, as demon-
strated by intraarterial injection of isoncotic or
hyperoncotic albumin [25] or by ECV-expansion
with equilibrated blood [26, 27]. Furthermore, the
natriuresis observed in the isolated perfused kidney,
either derived from chronically salt-loaded dogs [28]
or connected by cross-circulation to an acutely ECV-
expanded donor dog [26], in the absence of changes
in blood composition, renal plasma flow, glomerular
filtration, or filtration fraction strongly suggests an
intra- or extrarenal hormonal effect on tubular so-
dium reabsorption. The existence of such humoral
natriuretic activity is also supported by the present
observations in patients with primary aldosteronism
in whom the antinatriferic activity present in pre-
expansion plasma significantly increased after five
days of high sodium intake. Although GFR in
these patients was not determined, changes in hemo-
dynamic factors or in blood composition are least
likely to have significantly contributed to the resulting
natriuresis. Since urinary excretion of aldosterone was
similar during the control period and during high salt
intake, it is unlikely that changes in plasma activity of
this natriferic substance may have occurred. It may
therefore be inferred that in analogy to the experi-
mentally provoked "escape phenomenon" [12], pa-
tients with primary aldosteronism are protected
against continuous mineralocorticoid-induced so-
dium retention by the release of natriuretic factor(s)
possibly related to the antinatriferic activity present
in plasma fraction IV.
Although direct measurements of sodium trans-
port were not performed in this study, the inhibition
of the potential difference (PD) and short-circuit cur-
rent (SCC) by plasma fraction IV most probably
reflects an inhibition of net transepithelial sodium
transport [13]. Furthermore, the dose-dependent in-
hibition of PD and SCC in the presence of fraction IV
was not reversed by the addition of vasopressin at a
concentration which significantly stimulated sodium
transport in the absence of fraction IV. In previous
studies, this same fraction from postexpansion
plasma, when injected i.v. in the conscious rat, was
shown to be natriuretic in the absence of changes in
GFR, while mean potassium excretion remained
unaltered [5, 11]. In addition, this faction was dem-
onstrated to inhibit renal sodium-potassium-acti-
vated adenosine triphosphatase (Na-K-ATPase) in
vitro [11], an effect which was recently reported by
Gonick and Saldanha [4] and Hillyard, Lu, and Gon-
ick [29] who employed a low molecular weight frac-
tion from kidney tissue obtained with a similar
chromatographic procedure as used in the present
study. The authors were able to isolate a natriuretic
fraction from kidneys of volume-expanded rats which
inhibited frog skin sodium transport and renal Na-K-
ATPase activity in vitro. With the present chromato-
graphic technique, no estimate of the molecular
weight of the antinatriferic activity could be derived
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from the elution patterns, since adsorption to Seph-
adex®, as noted for vasopressin, may have occurred.
In preliminary studies, however, the passage through
an ultramembrane filter (UM-2) suggested an ap-
proximate mol wt of 1,000 or less [li}. These studies
also indicated that the activity is soluble in alcohol
and trichloroacetic acid, but is completely inactivated
when incubated with chymotrypsin, while resistant to
trypsin digestion [11].
Antinatriferic plasma activities probably of similar
molecular weight were previously reported by Buck-
alew, Martinez, and Green [2] and Nutbourne et al
[19], who observed an inhibitory effect of plasma
dialysates from ECV-expanded dogs on PD and SCC
of the toad bladder [2] and on PD and SCC of the
isolated frog skin mounted into the dog's extra-
corporeal circulation [191. Brown et al [30], however,
were unable to detect antinatriferic or natriuretic ac-
tivities with a mol wt of less than 10.000 in plasma
ultrafiltrates and dialysates from ECV-expanded
dogs. Some of the difficulties in recovering the hu-
moral sodium transport inhibitor from plasma ultra-
filtrates using Amicon ultrafiltration cells have been
pointed out by Buckalew [31]. A natriuretic plasma
fraction of low mol wt from ECV-expanded cows was
also described by Sedlakova, Lichardus, and Cort [8].
Finally, the elution patterns from Sephadex G-25 of
plasma fraction IV described in the present study
closely resemble those of the natriuretic fraction of
uremic serum, described by others [20, 32], which
inhibitis short-circuit current of anuran membranes,
including frog skin. The existence of such a humoral
inhibitor of sodium transport has recently gained
further support by the results of Buckalew and Nel-
son [33]. These authors demonstrated the appearance
of a natriuretic and antinatriferic substance of small
mol wt in plasma of ECV-expanded dogs. Although
gel chromatography applied in their study resulted in
slightly different elution patterns of the active mate-
rial, presumably due to the higher ionic strength (sus-
pension of lyophilized material in 7M hydrochloric
acid and elution with 0.1 M hydrochloric acid) of the
eluent, its mol wt of approximately 500, as estimated
from ultramembrane filtration, is in good agreement
with the preliminary results from our laboratory [11].
The results of the present study suggest that, prob-
ably depending on the previous state of body sodium
balance, an antinatriferic plasma fraction may be
isolated from human subjects undergoing acute or
chronic expansion of their extracellular fluid volume.
In analogy, Favre et al [34] have recently reported a
natriuretic and antinatriferic fraction isolated from
the urine of dogs by a similar chromatographic pro-
cedure as used in the present study. The activity of
this inhibitor of sodium transport also correlated well
with the state of sodium balance of these animals. We
therefore suggest that besides intrarenal physical and
hormonal factors, including renal prostaglandins [35,
36], tubular reabsorption of sodium in response to
changes in extracellular fluid volume may be modu-
lated in part by a circulating humoral activity of
small molecular size. The relative physiologic impor-
tance of this factor in the renal regulation of body
sodium and water homeostasis, as well as its final
purification, however, must await further in-
vestigation.
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